Cargando…
Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma
PURPOSE: Definitive radiation therapy is the mainstay of treatment for early stage laryngeal squamous cell carcinoma (LSCC). However, up to 30% of the patients do not respond to radiotherapy. Unfortunately, we are unable to predict which tumors are likely to respond to radiation, and which will be r...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533949/ https://www.ncbi.nlm.nih.gov/pubmed/26264462 http://dx.doi.org/10.1186/s12967-015-0621-y |